MLSS — Milestone Scientific Income Statement
0.000.00%
Last trade - 00:00
- $42.90m
- $36.95m
- $9.83m
- 40
- 15
- 32
- 19
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.37 | 5.44 | 10.3 | 8.81 | 9.83 |
Cost of Revenue | |||||
Gross Profit | 5.72 | 3.62 | 6.31 | 4.9 | 6.79 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 12.4 | 12.9 | 17.4 | 17.6 | 16.9 |
Operating Profit | -4 | -7.45 | -7.1 | -8.83 | -7.11 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.64 | -7.47 | -7.12 | -8.77 | -6.98 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.66 | -7.49 | -7.12 | -8.77 | -6.98 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -7.52 | -7.34 | -6.82 | -8.71 | -6.93 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.52 | -7.34 | -6.82 | -8.71 | -6.93 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.165 | -0.116 | -0.102 | -0.123 | -0.095 |